Literature DB >> 17267053

Memory consolidation and amnesia modify 5-HT6 receptors expression in rat brain: an autoradiographic study.

A Meneses1, L Manuel-Apolinar, C Castillo, E Castillo.   

Abstract

Traditionally, the search for memory circuits has been centered on examinations of amnesic and AD patients, cerebral lesions and, neuroimaging. A complementary alternative might be the use of autoradiography with radioligands. Indeed, ex vivo autoradiographic studies offer the advantage to detect functionally active receptors altered by pharmacological tools and memory formation. Hence, herein the 5-HT(6) receptor antagonist SB-399885 and the amnesic drugs scopolamine or dizocilpine were used to manipulate memory consolidation and 5-HT(6) receptors expression was determined by using [(3)H]-SB-258585. Thus, memory consolidation was impaired in scopolamine and dizocilpine treated groups relative to control vehicle but improved it in SB-399885-treated animals. SB-399885 improved memory consolidation seems to be associated with decreased 5-HT(6) receptors expression in 15 out 17 brain areas. Scopolamine or dizocilpine decreased 5-HT(6) receptors expression in nine different brain areas and increased it in CA3 hippocampus or other eight areas, respectively. In brain areas thought to be in charge of procedural memory such basal ganglia (i.e., nucleus accumbens, caudate putamen, and fundus striate) data showed that relative to control animals amnesic groups showed diminished (scopolamine) or augmented (dizocilpine) 5-HT(6) receptor expression. SB-399885 showing improved memory displayed an intermediate expression in these same brain regions. A similar intermediate expression occurs with regard to amygdala, septum, and some cortical areas in charge of explicit memory storage. However, relative to control group amnesic and SB-399885 rats in the hippocampus, region where explicit memory is formed, showed a complex 5-HT(6) receptors expression. In conclusion, these results indicate neural circuits underlying the effects of 5-HT(6) receptor antagonists in autoshaping task and offer some general clues about cognitive processes in general.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17267053     DOI: 10.1016/j.bbr.2006.11.048

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  6 in total

1.  An association study of the genetic polymorphisms in 13 neural plasticity-related genes with semantic and episodic memories.

Authors:  Pingyuan Gong; Zijian Zheng; Wanyu Chi; Xu Lei; Xiaodong Wu; Dongmei Chen; Kejin Zhang; Anyun Zheng; Xiaocai Gao; Fuchang Zhang
Journal:  J Mol Neurosci       Date:  2011-07-05       Impact factor: 3.444

2.  Antidepressant-like activity of EMD 386088, a 5-HT6 receptor partial agonist, following systemic acute and chronic administration to rats.

Authors:  Magdalena Jastrzębska-Więsek; Agata Siwek; Anna Partyka; Bernadeta Szewczyk; Magdalena Sowa-Kućma; Anna Wasik; Marcin Kołaczkowski; Anna Wesołowska
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-06-16       Impact factor: 3.000

3.  Effects of 5-HT6 receptor antagonism and cholinesterase inhibition in models of cognitive impairment in the rat.

Authors:  B Marcos; T T Chuang; F J Gil-Bea; M J Ramirez
Journal:  Br J Pharmacol       Date:  2008-07-14       Impact factor: 8.739

Review 4.  5-HT3 Receptors: A Potential Therapeutic Target for Epilepsy.

Authors:  Hongyan Zhao; Yang Lin; Shurui Chen; Xin Li; Hongliang Huo
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

5.  5-HT6 receptor agonism facilitates emotional learning.

Authors:  Marcela Pereira; Bruno J Martynhak; Roberto Andreatini; Per Svenningsson
Journal:  Front Pharmacol       Date:  2015-09-16       Impact factor: 5.810

6.  Role of Hippocampal 5-HT6 Receptors in Glucocorticoid-Induced Enhancement of Memory Consolidation in Rats.

Authors:  Rajab Mohamad Rezaei; Abdolhossein Shiravi; Seyed Ali Seyedinia; Nasroallah Moradi Kor; Abbas Ali Vafaei; Ali Rashidy-Pour
Journal:  Basic Clin Neurosci       Date:  2020-07-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.